One hundred and forty-eight isolates of bacteria from 20 intraoral odontogenic abscesses were tested for their susceptibility to spiramycin and metronidazole alone or in combination. All isolates, except Rothia spp. (one), Enterococcus avium (three), Haemophilus parainfluenzae (one) and Staphylococcus aureus (one) were sensitive to spiramycin and/or metronidazole. Among the anaerobes, spiramycin as well as metronidazole showed good antimicrobial activity against species of P r e 
Introduction
Oral abscesses, like other odontogenic infections, are mixed infections with anaerobes outnumbering aerobes. [1] [2] [3] [4] [5] [6] [7] Successful treatment of oral abscesses requires incision and drainage, although antibiotics are often used to resolve these infections. The penicillins have been widely used because of their historical effectiveness, minimal toxicity and relative low cost, but the emergence of penicillinresistant anaerobes 1, [7] [8] [9] [10] has prompted the use of metronidazole.
Metronidazole has excellent activity against anaerobes but possesses little or no activity against aerobes. The addition of spiramycin to metronidazole was suggested [11] [12] [13] and has been studied in the field of periodontology with the generation of limited antimicrobial susceptibility data. 14, 15 The purpose of this study was to determine spiramycin and metronidazole susceptibilities, alone or in combination, against bacterial isolates of odontogenic abscesses.
Materials and methods

Patients
Samples included in this study were obtained from 20 patients (13 males, seven females) who presented to the Oral and Maxillofacial Surgery Department, Harbor UCLA (University of California, Los Angeles) Medical Center, Torrance, CA, USA, with an acute dentoalveolar abscess. None of the patients reported or showed signs of any concurrent systemic disease or had been under antibiotic therapy for the previous 6 months.
Collection of specimens
Aspirated specimens for bacteriological cultures were obtained by using a 2 mL disposable syringe after the mucosa had been disinfected with a tincture of iodine saturated swab. The specimen was transferred to an Anaport vial (Scott Laboratories, Inc., West Warwick, RI, USA), transported to the laboratory and stored at room temperature (less than 12 h) until cultured.
Culture of microorganisms
Aspirated specimens were inoculated on to two sheep blood agar plates, MacConkey agar and coliston-nalidixic acid agar and into Schaedler's broth. All were incubated aerobically in a 5% CO 2 incubator for 24 h except for one blood agar plate which was incubated anaerobically for up to 8 days in an anaerobic chamber (Anaerobe Systems, Inc., Santa Clara, CA, USA). Schaedler's broth was subcultured after 3 days of incubation on to supplemented sheep blood agar with and without 20 mg/L of gentamicin and
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In-vitro activity of spiramycin and metronidazole alone or in combination against clinical isolates from odontogenic abscesses incubated anaerobically for 4 days. A stereomicroscope was used to select colonies of different morphologies and standard procedures were used to isolate the aerobic and anaerobic bacteria.
Identification of bacteria
Aerobic identification was performed according to standard procedures. 16 Anaerobic bacteria were identified by VPI (Virginia Polytechnic Institute, Blacksburg, VA, USA) techniques, which included Gram's stain, gas-liquid chromatography and prereduced anaerobically sterilized media and by bioMérieux Vitek ANI cards (Hazelwood, MO, USA).
Antibiotic susceptibility tests
The MICs of spiramycin and metronidazole (provided by Rhône-Poulenc Rorer Laboratories, Paris, France) were determined for aerobes and anaerobes by the agar dilution method. American Type Culture Collection (Rockville, MD, USA) anaerobic bacteria, Bacteroides fragilis (ATCC 25285), Bacteroides thetaiotaomicron (ATCC 29741) and Enterococcus faecalis (ATCC 29212) were used as quality control organisms. Wilkens-Chalgren agar plates supplemented with 5% newborn calf serum and 1.5% Filde's enrichment (Difco Laboratories, Detroit, MI, USA) containing two-fold dilutions of spiramycin or metronidazole were inoculated with 10 5 organisms using a calibrated loop. Anaerobes and aerobes were incubated for 48 and 24 h in an anaerobic chamber (Anaerobe Systems, Inc.) and in a 5% CO 2 incubator, respectively. The last dilution showing no growth was chosen to be the MIC. Potential antimicrobial synergy, as described by Brook, 14, 15 was assessed by adding 0.125 mg/L of either metronidazole or spiramycin to each dilution of the other antimicrobial agent to be tested. The combination was considered potentially synergic when the MIC of the associated antibiotic was reduced by four-fold or more.
Results
Bacteriological findings
All oral abscesses investigated (20) , yielded a positive growth. As shown in the Tables, a total of 148 isolates (mean of seven isolates per specimen) were found. Ninetyseven (66%) were anaerobes representing 13 genera and 34 species, and 51 (34%) were aerobes or facultative aerobes representing six genera and 18 species. Among the aerobes (Table I) , the predominant isolates were Streptococcus spp. (44 isolates, 30% of all isolates, 85% of all aerobes). Among the anaerobes (Table II) , the predominant isolates were Eubacterium spp. (28 isolates, 19% of all isolates, 29% of all anaerobes) and Prevotella spp. (27 isolates, 18% of all isolates, 29% of all anaerobes).
Antibiotic susceptibilities
The mean MICs are presented in Tables I and II Among the anaerobes (97 tested), 89 (92%) were sensitive to metronidazole. Only eight isolates, Lactobacillus rugosae, Lactobacillus acidophilus (two), Lactobacillus minutus, Lactobacillus fermentum, Actinomyces israeli and Gemella morbillorum (two), were resistant to metronidazole. Eighty-five anaerobes (87%) were sensitive to spiramycin. Only 12 isolates, Veillonella parvula (six), Fusobacterium nucleatum (five) and Bifidobacterium catenulatum (one), were resistant to spiramycin.
Among the aerobes (51 tested), 45 (88%) were sensitive to spiramycin. Only six isolates, E. avium (three), H. parainfluenzae, Rothia spp. and S. aureus, were resistant to spiramycin. All the aerobes were resistant to metronidazole.
The MICs of spiramycin and metronidazole for 25 isolates (17%), 21 Eubacterium spp. isolates, two lactobacilli, one Peptostreptococcus sp. and one Clostridium clostridiiforme, were significantly reduced by the addition of the other antibiotic.
Discussion
This study confirms the polymicrobial nature as well as the importance of anaerobic bacteria in intraoral abscesses as previously described. [3] [4] [5] 7 However, no specific bacterium was isolated from all the abscesses and the spectrum of bacterial species was similar to other odontogenic oral isolates. Fifty-two bacterial species were isolated; 18 aerobic and 34 anaerobic species.
The results presented here show that among the 148 isolates tested, 96% were susceptible to spiramycin and/or metronidazole. Only 4% of clinical isolates were resistant to both antimicrobials, but none are suspected of being involved in the pathogenicity of odontogenic abscesses. Spiramycin and metronidazole, when used alone, were effective against 88% of the aerobes and 92% of the anaerobes, respectively.
The MICs for 17% of the isolates were significantly reduced and may be considered synergic when spiramycin and metronidazole were used in combination against Eubacterium (21 isolates), lactobacilli spp. (two), Peptostreptococcus sp. (one) and C. clostridiiforme (one). It is possible that synergy could be demonstrated for more isolates if different concentrations including 0.125 mg/L of either metronidazole or spiramycin were used. These results agree with previous in-vitro findings 11, 12, 14, 15 
except against Prevotella melanogenica (Bacteroides melanogenicus).
14 This difference may be related to the isolate. Videau 11 demonstrated synergy against other organisms, which may be explained by antimicrobial usage for the intervening years with increasing tolerance to antimicrobial agents.
The use of metronidazole has increased with the emergence of penicillin-resistant oral bacteria following penicillin chemotherapy. 1, [7] [8] [9] [10] Metronidazole has excellent activity against anaerobes but no activity against aerobes and therefore requires to be used in conjunction with other agents. Antimicrobial combinations for chemotherapy of oral infections have been proposed and spiramycin was chosen as a possibility because of its good activity against both aerobes and anaerobes, 5, [11] [12] [13] 17 and its pharmacokinetics was found to be suitable and could achieve high concentrations in alveolar bone and gingival tissue which exceeded serum levels. 12, 18, 19 Finally, the combination of spiramycin and metronidazole has been used in periodontal disease treatment and its success reported by a number of investigators. 20, 21 Today, this combination is commonly used in France as well as in Canada.
In summary, there is no single antimicrobial agent which can be used appropriately for the treatment of mixed infections. Metronidazole is effective against most anaerobic bacteria including Prevotella, Eubacterium, Peptostreptococcus, Bacteroides and Porphyromonas species, which are found and/or suspected to be involved in the pathogenicity of oral diseases. Spiramycin by itself possesses good activity against aerobes and anaerobes of the oral flora, and this study strongly suggests that the combination with metronidazole is potentially synergic and appropriate for treatment of odontogenic abscesses. 
